7th International CAA Conference

Welcome to the 7th International Cerebral Amyloid Angiopathy Conference. We have crafted a program that features cutting-edge research, translational ideas for clinical trials, and new knowledge on prevention and treatment of manifestations of CAA such as hemorrhagic stroke.

Eric Smith, MD, MPH
Steven Greenberg M.D. Ph.D.
Mark van Buchem MD, PhD
253
days
19
hours
54
min
45
sec

Message from the Chair

 

 

Welcome to the 7th International Cerebral Amyloid Angiopathy Conference. We have crafted a program that features cutting-edge research, translational ideas for clinical trials, and new knowledge on prevention and treatment of manifestations of CAA such as hemorrhagic stroke.

Because of the effects of the COVID pandemic, the Conference will now take place online over two days, 1-2 October, 2020. Details and the revised program will be available soon. Abstracts submissions will be accepted for electronic or oral presentation.

Our field of CAA research is being transformed by an expanding array of CAA biomarkers, better radio-pathological correlation, new model systems, and increasing therapeutic options for trials. Attend the Conference to share your own work on CAA, learn about new research and techniques, and gather information on diagnosis and treatment to help your clinical practice. The Conference covers all aspects of CAA research including molecular, tissue- or animal-based, human subject research, and clinical trails. Attendees include basic scientists, clinicians, and clinical researchers.”

Warmest regards,

 

Eric Smith, MD, MPH

Professor of Neurology, University of Calgary

Chair, 7th International CAA Conference Organizing Committee

abstract submission

 

 

Dear All,
 
We are pleased to announce that the virtual online International CAA conference of 1-2 October, 2020, is accepting abstracts for presentation. The deadline for submissions is July 17, 2020
 
Any basic or clinical science related to CAA is eligible for presentation at the meeting. This includes basic research on causes and mechanisms of CAA, the relationship between CAA and Alzheimer’s Disease, epidemiology, neuropathology, biomarkers, therapeutics, clinical trials, outcomes, and clinical care. 
 
Abstracts will be accepted for oral presentation at the virtual conference, or for presentation at an online e-poster.
 
We look forward to helping you disseminate your research on CAA.
 
Sincerely yours,
Eric Smith
Mark van Buchem 
Steve Greenberg
 

 

Submission Guidelines
–        All abstracts must be submitted via office@icaaconference.org ONLY. Abstracts sent by fax will not be accepted.

–        All abstracts should be written in English.
–      It is the responsibility of the presenting author and the submitter to review the submission status & information and correct them. Submitters are responsible for any typo error in the abstract.
–        The presenting author’s name should be underlined.
–        The abstract should be limited to;
o   400 words (text only), or
o   300 words and up to 2 images or tables
 
Important Dates
Call for Abstract                                June 18, 2020
Abstract Submission Due                 July 17, 2020
 


Scientific Program Committee

Contact

MESSAGE SENT!

Organizing Committee 2020

Sponsors